Reasons to Retain Inari Medical Stock in Your Portfolio for Now [Yahoo! Finance]
Inari Medical, Inc. (NARI)
Company Research
Source: Yahoo! Finance
NARI is well-poised for growth on the back of a huge market opportunity for its products and its commitment to understanding the venous system. However, the company's dependency on the adoption of its products is concerning. Shares of this Zacks Rank #3 (Hold) company have lost 18.1% in the past six months against the industry's 6.8% growth. The S&P 500 Index has risen 26.2% in the same time frame. NARI, with a market capitalization of $2.99 billion, is a commercial-stage medical device company. It seeks to develop products for treating and changing the lives of patients suffering from venous diseases. The company's negative earnings yield of 0.1% compares favorably with the industry's (-3.8%). It delivered a trailing four-quarter average earnings surprise of 24.77%. Zacks Investment Research Image Source: Zacks Investment Research What's Driving NARI's Performance? Inari Medical's top-line growth is primarily driven by its ClotTriever and FlowTriever products that targe
Show less
Read more
Impact Snapshot
Event Time:
NARI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NARI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NARI alerts
High impacting Inari Medical, Inc. news events
Weekly update
A roundup of the hottest topics
NARI
News
- NARI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Inari Medical, Inc. Is Fair to ShareholdersBusiness Wire
- Stryker to buy Inari Medical for nearly $5B [Yahoo! Finance]Yahoo! Finance
- Shareholder Alert: Ademi LLP investigates whether Inari Medical, Inc. is obtaining a Fair Price for its Public ShareholdersBusiness Wire
- Stryker confirms deal to purchase Inari Medical for $80 a share [Seeking Alpha]Seeking Alpha
- Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Inari Medical, Inc. (NARI) and Encourages Investors to Learn More About the InvestigationAccesswire
NARI
Earnings
- 10/28/24 - Miss
NARI
Sec Filings
- 1/6/25 - Form SC14D9C
- 1/6/25 - Form 8-K
- 1/6/25 - Form 144
- NARI's page on the SEC website